COVID-19 : Cynbiose and VirPath team up in a collaborative R&D project related to the SARS-CoV-2 outbreak.
8 June 2020Cynbiose in partnership with the academic laboratory VirPath announced today the launch of the COVIBIOSE project.
The COVIBIOSE project aims to develop and characterize an innovative non-human primate (NHP) preclinical model to study the pathophysiology of the infection by SARS-CoV-2 and evaluate the efficacy of therapeutic or prophylactic candidates in order to fast-track them to clinic trials.
This initiative is coordinated by the French cluster Lyonbiopôle and supported by the Auvergne-Rhône-Alpes region.
More information available in the press release.
